SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-009767
Filing Date
2024-02-01
Accepted
2024-02-01 16:01:10
Documents
12
Period of Report
2024-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K clsd-20240131.htm   iXBRL 8-K 40705
  Complete submission text file 0000950170-24-009767.txt   153926

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clsd-20240131.xsd EX-101.SCH 24861
13 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20240131_htm.xml XML 4717
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 24586830
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)